市场调查报告书
商品编码
1347608
医用泡沫市场:2023-2028 年全球行业趋势、份额、规模、增长、机会和预测Medical Foam Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球医用泡沫市场规模达到291亿美元。展望未来,IMARC集团预计到2028年市场规模将达到427亿美元,2023-2028年復合年增长率(CAGR)为6.4%。
医用泡沫是指用于多种医疗设备、组件和支撑材料的抗菌产品,例如医疗行业的手术单、伤口敷料和床上用品。它采用多孔聚氨酯、聚合物和金属製造。医用泡沫还广泛用于假肢衬垫、定制矫形器、密封造口设备和身体足底压力释放设备。它具有多种特性,例如防水、抗拉、抗真菌、柔软、耐用、无菌和多功能性,因此适合保护性包装用途。医用泡沫具有缓解压力的功能,可适应患者的体形,有助于提供舒适、放鬆和缓解压力缓解点。目前,它有刚性、柔性和模製产品类型。
全球老年人口不断增加,更容易患各种慢性病,这是推动市场增长的关键因素之一。医用泡沫在大手术后的患者康復过程中发挥着至关重要的作用,因为它们广泛用于床上用品和缓衝产品以提高舒适度。此外,医用泡沫由于其优异的抗压缩形变性、衝击吸收性和多功能性等多种特性,在医疗系统缓冲和伤口敷料等众多应用中的使用不断增加,有利于市场增长。除此之外,冠状病毒病(COVID-19)和猪流感等流行病爆发病例的增加,以及人们对个人卫生相关健康问题的日益关注,都为市场增长提供了动力。此外,医疗呼吸和麻醉系统和设备中对热湿交换(HME)泡沫的需求不断增长,这些泡沫可提供一致和受控的氧气和气体摄入,同时确保无菌条件,这对市场增长产生了积极影响。其他因素,包括医疗行业的大幅扩张、对植入式医疗设备的需求不断增加以及从传统伤口护理产品向先进伤口护理产品的转变,预计将推动市场增长。
The global medical foam market size reached US$ 29.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 42.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028.
Medical foam refers to an antimicrobial product used in numerous medical devices, components, and support materials, such as surgical drapes, wound dressing, and bedding materials in the healthcare industry. It is manufactured using cell polyurethane, polymers and metals. Medical foam is also widely used in prosthetic padding, custom orthotics, sealing ostomy equipment and body underfoot pressure relief equipment. It exhibits various properties, such as water, strain and fungal resistance, softness, durability, sterility, and versatility, thus making it suitable for protective packaging purposes. Medical foams offer compression relieving capabilities that adapt to the patient's body shape and assist in providing comfort, relaxation and alleviating pressure relief points. Currently, it is available in rigid, flexible, and molded product types.
The rising geriatric population across the globe that are more prone to developing various chronic ailments represents one of the key factors driving the growth of the market. Medical foam plays a vital role during patient recovery post major surgeries as they are widely used in bedding and cushioning products to enhance comfort. Additionally, the increasing usage of medical foam in numerous applications, such as medical system cushioning and wound dressings, due to its various properties, such as excellent compression-set resistance, impact-absorbing and versatility, is favoring the market growth. Apart from this, increasing cases of epidemic outbreaks, such as coronavirus disease (COVID-19) and swine flu, along with rising health concerns among people related to personal hygiene, are providing an impetus to the market growth. Moreover, the increasing demand for heat and moisture exchange (HME) foams in medical breathing and anesthesia systems and equipment that provide a consistent and controlled oxygen and gas intake, while also ensuring sterile conditions are positively impacting the market growth. Other factors, including the significant expansion in the medical industry, increasing demand for implantable medical devices, and the shifting inclination from traditional to advanced wound care products are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical foam market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, material and application.
Rigid
Flexible
Molded
Polymers
Metals
Other
Bedding and Cushioning
Medical Packaging
Medical Devices and Components
Prosthetics and Wound Care
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Medical Solutions Group Plc, BASF SE, Draka Interfoam B.V., Foamtec Medical, Freudenberg Performance Materials, FXI, General Plastics Manufacturing Company Inc., Global Medical Foam Inc., Inoac Corporation, Recticel NV, Rogers Corporation, SEKISUI CHEMICAL CO. LTD. and Ufp Technologies Inc.